Marc Forth
Chief Exectuive Officer, Director at AEON Biopharma, Inc. (AEON) since July 2023
Marc Forth has filed 6 insider reports with the SEC since July 2023, as chief Exectuive Officer and director at AEON Biopharma, Inc. (AEON). The latest filing, on June 22, 2026, reports grant or award at AEON Biopharma, Inc. (AEON).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Marc Forth is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| AEON AEON Biopharma, Inc. | Chief Exectuive Officer, Directorsince July 2023 | 973,231 | $0.1759 | Jun 22, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 17, 2026AEONDirector Forth Marc was granted 222,684 shares, increasing direct ownership by 30% to 973,231 unitsForm 4Grant or award
- May 21, 2025AEONSEC Form 4 filed by Director Forth MarcForm 4Grant or award
- Aug 31, 2024AEONCHIEF EXECTUIVE OFFICER Forth Marc was granted 470,692 shares, increasing direct ownership by 168% to 750,547 unitsForm 4Grant or award
- Mar 19, 2024AEONSEC Form 4 filed by Forth MarcForm 4Grant or award
- Jul 21, 2023AEONSEC Form 4 filed by Forth MarcForm 4Grant or award
- Jul 21, 2023AEONMarc Forth became an insiderForm 3New insider
Compare Marc Forth with
- Marc Forth vs Timothy P Lynch1 shared
- Marc Forth vs Shelley B Thunen1 shared
- Marc Forth vs Robert J Palmisano1 shared
- Marc Forth vs Jost Fischer1 shared
- Marc Forth vs Eric G Carter1 shared
- Marc Forth vs John Bencich1 shared
Other insiders at the same companies
- Timothy P LynchAEON
- Shelley B ThunenAEON
- Robert J PalmisanoAEON
- Jost FischerAEON
- Eric G CarterAEON
- John BencichAEON
- Chad OhAEON
- Alexander Blair WilsonAEON
- Jennifer SyAEON
- Robert E. BancroftAEON
- Daewoong Co., LtdAEON
Questions about Marc Forth
- What is Marc Forth's role at AEON Biopharma, Inc.?
- Marc Forth reports to the SEC as chief Exectuive Officer and director at AEON Biopharma, Inc. (AEON), according to the latest filing on June 22, 2026.
- How many shares does Marc Forth own?
- After the latest filing that states it, Marc Forth directly owned 973,231 shares of AEON Biopharma, Inc. (AEON). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Marc Forth bought or sold stock recently?
- No open-market purchases or sales by Marc Forth are on file. The filings report grant or award.
- How do I get alerts when Marc Forth files?
- Follow Marc Forth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Marc Forth (SEC CIK 0001816988). Totals count each trade once, skipping amendments whose original is on file, from Jul 25, 2023 on. View on SEC EDGAR